Noch Fragen? 0800 / 33 82 637

Erweiterte Suche

Ihre Suche ergab 48 Treffer.


Insulin-like Growth Factors and Cancer

From Basic Biology to Therapeutics

Produktform: Buch / Einband - fest (Hardcover)


This book explores the insulin-like growth factor system and its vital role in cancer development and progression. Covers biology, epidemiology and the therapeutic potential of inhibiting receptors using newly discovered antibodies and kinase inhibitors.

Verlag: Springer US, Auflage 1, 284 Seiten

Erscheinungsdatum: 15.09.2011

160,49 € inkl. MwSt.
kostenloser Versand

lieferbar - Lieferzeit 10-15 Werktage

zum Artikel

Antibody-Drug Conjugates and Immunotoxins

From Pre-Clinical Development to Therapeutic Applications

Produktform: Buch / Einband - flex.(Paperback)


This volume collets leading research on antibody-drug conjugates and immunotoxins. It examines all aspects of ADCs and ITs from clinical development through to targeted therapeutic applications and the latest technologies.

Verlag: Springer US, Auflage 1, 378 Seiten

Erscheinungsdatum: 28.01.2015

160,49 € inkl. MwSt.
kostenloser Versand

lieferbar - Lieferzeit 10-15 Werktage

zum Artikel

DNA Topoisomerases and Cancer

Produktform: Buch / Einband - flex.(Paperback)

Verlag: Springer US, Auflage 1, 443 Seiten

Erscheinungsdatum: 25.10.2013

213,99 € inkl. MwSt.
kostenloser Versand

lieferbar - Lieferzeit 10-15 Werktage

zum Artikel

Nuclear Signaling Pathways and Targeting Transcription in Cancer

Produktform: Buch / Einband - flex.(Paperback)


This book summarizes the roles, significance, and potential therapeutic targeting of transcriptional factors (TFs) from the perspective of signaling cascade. It details the physiologic and pathologic roles of TFs in specific representative organ systems.

Verlag: Springer US, Auflage 1, 439 Seiten

Erscheinungsdatum: 23.08.2015

160,49 € inkl. MwSt.
kostenloser Versand

lieferbar - Lieferzeit 10-15 Werktage

zum Artikel

Handbook of Anticancer Pharmacokinetics and Pharmacodynamics

Produktform: Buch / Einband - fest (Hardcover)


This book offers a detailed, step-by-step guide to the successful design and approval of anticancer drugs. It covers all steps, from the identification of cancer-specific molecular targets to clinical trial design and all the phases of clinical trials.

Verlag: Springer US, Auflage 2, 836 Seiten

Erscheinungsdatum: 11.01.2014

267,49 € inkl. MwSt.
kostenloser Versand

lieferbar - Lieferzeit 10-15 Werktage

zum Artikel

Nitric Oxide (NO) and Cancer

Prognosis, Prevention, and Therapy

Produktform: Buch / Einband - flex.(Paperback)


The Nobel Prize in Physiology and Medicine was awarded in 1998 to Doctors Furchgott, Ignarro, and Murad for their discoveries concerning “Nitric oxide (NO) as a signaling molecule in the cardiovascular system.” NO-inducing cell signaling events within the cell producing it and the diffusibility to NO in other cells have led to the discovery of many other physiological functions in many different types of cells including cancer. Noteworthy, nitroglycerin that has been used for the treatment of chest pain and associated cardiovascular diseases is currently being investigated for its therapeutic effect in clinical studies in patients with cancer. Further, several NO donor compounds have shown, in preclinical studies, anti-tumoral chemopreventive and therapeutic activities. “Nitric Oxide and Cancer: Prognosis, Prevention and Therapy”, edited by Benjamin Bonavida, Ph.D., reviews several novel applications of NO in cancer, a new field that has rapidly gained credibility and understanding at the biochemical and molecular levels. The various chapters in this comprehensive volume (25 contributions), written by noted experts in the field, bring up-to-date our current understanding and prospective future clinical applications of NO.

Verlag: Springer US, Auflage 1, 250 Seiten

Erscheinungsdatum: 05.09.2012

213,99 € inkl. MwSt.
kostenloser Versand

lieferbar - Lieferzeit 10-15 Werktage

zum Artikel

Nitric Oxide (NO) and Cancer

Prognosis, Prevention, and Therapy

Produktform: Buch / Einband - fest (Hardcover)


The Nobel Prize in Physiology and Medicine was awarded in 1998 to Doctors Furchgott, Ignarro, and Murad for their discoveries concerning “Nitric oxide (NO) as a signaling molecule in the cardiovascular system.” NO-inducing cell signaling events within the cell producing it and the diffusibility to NO in other cells have led to the discovery of many other physiological functions in many different types of cells including cancer. Noteworthy, nitroglycerin that has been used for the treatment of chest pain and associated cardiovascular diseases is currently being investigated for its therapeutic effect in clinical studies in patients with cancer. Further, several NO donor compounds have shown, in preclinical studies, anti-tumoral chemopreventive and therapeutic activities. “Nitric Oxide and Cancer: Prognosis, Prevention and Therapy”, edited by Benjamin Bonavida, Ph.D., reviews several novel applications of NO in cancer, a new field that has rapidly gained credibility and understanding at the biochemical and molecular levels. The various chapters in this comprehensive volume (25 contributions), written by noted experts in the field, bring up-to-date our current understanding and prospective future clinical applications of NO.

Verlag: Springer US, Auflage 1, 250 Seiten

Erscheinungsdatum: 17.06.2010

213,99 € inkl. MwSt.
kostenloser Versand

lieferbar - Lieferzeit 10-15 Werktage

zum Artikel

Insulin-like Growth Factors and Cancer

From Basic Biology to Therapeutics

Produktform: Buch / Einband - flex.(Paperback)


This book explores the insulin-like growth factor system and its vital role in cancer development and progression. Covers biology, epidemiology and the therapeutic potential of inhibiting receptors using newly discovered antibodies and kinase inhibitors.

Verlag: Springer US, Auflage 1, 284 Seiten

Erscheinungsdatum: 24.10.2013

160,49 € inkl. MwSt.
kostenloser Versand

lieferbar - Lieferzeit 10-15 Werktage

zum Artikel

Tumor Metabolome Targeting and Drug Development

Produktform: Buch / Einband - fest (Hardcover)

Verlag: Springer US, Auflage 1, 198 Seiten

Erscheinungsdatum: 09.01.2014

160,49 € inkl. MwSt.
kostenloser Versand

lieferbar - Lieferzeit 10-15 Werktage

zum Artikel

Antibody-Drug Conjugates and Immunotoxins

From Pre-Clinical Development to Therapeutic Applications

Produktform: Buch / Einband - fest (Hardcover)


This volume collets leading research on antibody-drug conjugates and immunotoxins. It examines all aspects of ADCs and ITs from clinical development through to targeted therapeutic applications and the latest technologies.

Verlag: Springer US, Auflage 1, 378 Seiten

Erscheinungsdatum: 12.12.2012

160,49 € inkl. MwSt.
kostenloser Versand

lieferbar - Lieferzeit 10-15 Werktage

zum Artikel